Matches in DBpedia 2016-04 for { ?s ?p "Disufenton sodium (NXY-059, Cerovive) is the disulfonyl derivative of the neuroprotective spin trap phenylbutylnitrone or \"PBN\". It was under development at the drug company AstraZeneca. A 2005 phase-3 clinical trial called \"SAINT-1\" reported some efficacy in the acute treatment of ischemia injury due to stroke. However, a 2006 attempt to repeat this trial indicated no significant activity."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Disufenton_sodium comment "Disufenton sodium (NXY-059, Cerovive) is the disulfonyl derivative of the neuroprotective spin trap phenylbutylnitrone or \"PBN\". It was under development at the drug company AstraZeneca. A 2005 phase-3 clinical trial called \"SAINT-1\" reported some efficacy in the acute treatment of ischemia injury due to stroke. However, a 2006 attempt to repeat this trial indicated no significant activity.".